Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pietra

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Blood|April 12, 2007
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutationFrancesco Passamonti, Maria Luigia Randi, Elisa Rumi, et al.
Blood|May 25, 2016
LNK mutations in familial myeloproliferative neoplasmsElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Haematologica|August 8, 2015
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemiaElisa Rumi, Irene Bertozzi, Ilaria C Casetti, et al.
Oncotarget|December 20, 2017
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteriaElisa Rumi, Emanuela Boveri, Marta Bellini, et al.
Hematological Oncology|June 26, 2020
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinibElisa Rumi, Emanuela Sant'Antonio, Chiara Cavalloni, et al.
American Journal of Hematology|January 18, 2022
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcomeMarianna Rossi, Maria Elena Nizzoli, Anna Gallì, et al.
Blood|November 8, 2019
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasmsChristian A Di Buduo, Vittorio Abbonante, Caroline Marty, et al.
Blood|January 31, 2022
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasmsOscar Borsani, Paul Bastard, Jérémie Rosain, et al.
Blood|August 21, 2009
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosisLuca Malcovati, Matteo G Della Porta, Daniela Pietra, et al.
Blood|November 8, 2019
Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanningJessica L Bridgford, Su Min Lee, Christine M M Lee, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Blood|April 12, 2007
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutationFrancesco Passamonti, Maria Luigia Randi, Elisa Rumi, et al.
Blood|May 25, 2016
LNK mutations in familial myeloproliferative neoplasmsElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Haematologica|August 8, 2015
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemiaElisa Rumi, Irene Bertozzi, Ilaria C Casetti, et al.
Oncotarget|December 20, 2017
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteriaElisa Rumi, Emanuela Boveri, Marta Bellini, et al.
Hematological Oncology|June 26, 2020
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinibElisa Rumi, Emanuela Sant'Antonio, Chiara Cavalloni, et al.
American Journal of Hematology|January 18, 2022
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcomeMarianna Rossi, Maria Elena Nizzoli, Anna Gallì, et al.
Blood|November 8, 2019
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasmsChristian A Di Buduo, Vittorio Abbonante, Caroline Marty, et al.
Blood|January 31, 2022
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasmsOscar Borsani, Paul Bastard, Jérémie Rosain, et al.
Blood|August 21, 2009
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosisLuca Malcovati, Matteo G Della Porta, Daniela Pietra, et al.
Blood|November 8, 2019
Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanningJessica L Bridgford, Su Min Lee, Christine M M Lee, et al.
Pageof 10